Skip to main content

Table 2 Characteristics of the disease recurrences

From: Risk factors for the recurrence of relapsing polychondritis

 

Present study

Total recurrence

 Total number of patients with recurrence (number)

25

 Total number of recurrences (times)

64

 Mean number of recurrences (times/person)

2.56

 Person-years

0.16

 Major recurrence, n (%)

11 (17.2)

 Minor recurrence, n (%)

53 (82.8)

Initial recurrence, n=25

 Median age at initial recurrence (years)

51 (40–67)

 Median days to initial recurrence (days)

202 (55–382)

 Major recurrence, n (%)

6 (24.0)

 Minor recurrence, n (%)

19 (76.0)

 Median PSL doses at initial recurrence (mg)

10 (5–12.75)

 Symptoms at initial recurrence

  Tracheobronchial involvement

10 (40.0)

  Auricular involvement

6 (24.0)

  Nasal involvement

3 (12.0)

  Articular involvement

3 (12.0)

  Eye involvement

2 (8.0)

  Vestibulocochlear involvement

2 (8.0)

  Encephalitis

1 (4.0)

Concordance of initial symptoms and symptoms at initial recurrence

17 (68.0)

  1. Numbers are presented as means (SD) or medians [interquartile range: 25–75%]. Some patients had several symptoms at the initial recurrence. Major recurrence: required admission. Minor recurrence: did not require admission. PSL prednisolone